Cargando…
Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446002/ https://www.ncbi.nlm.nih.gov/pubmed/28213386 http://dx.doi.org/10.1136/annrheumdis-2014-207178corr1 |
| _version_ | 1783239001881182208 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5446002 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54460022017-06-08 Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs Ann Rheum Dis Correction BMJ Publishing Group 2017-03 2017-02-17 /pmc/articles/PMC5446002/ /pubmed/28213386 http://dx.doi.org/10.1136/annrheumdis-2014-207178corr1 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ |
| spellingShingle | Correction Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| title | Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| title_full | Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| title_fullStr | Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| title_full_unstemmed | Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| title_short | Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| title_sort | erratum: efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446002/ https://www.ncbi.nlm.nih.gov/pubmed/28213386 http://dx.doi.org/10.1136/annrheumdis-2014-207178corr1 |